home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410n.zip
/
M94A2555.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
2KB
|
36 lines
Document 2555
DOCN M94A2555
TI Epidemiological trends in HIV infected patients in Buenos Aires.
DT 9412
AU Avolio J; Rimoldi I; Arreseigor T; Provincial Reference Center for AIDS,
La Plata, Argentina.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):278 (abstract no. PC0033). Unique
Identifier : AIDSLINE ICA10/94370020
AB OBJECTIVE: To describe the distribution by sex, age and risk factors of
HIV infected people, as well as trends in two risk groups from the
Province of Buenos Aires, Argentina (population 13.2 million). METHODS:
HIV-1 infection was diagnosed according to the algorithm: peripheral lab
EIA or PA--Reference Center for AIDS EIA or PA EIA2-IFA-Wb-LIA. EIA
(Abbott, O. Teknika) and WB (Sorin, O. Teknika). RESULTS: From Jan 1989
to Apr 1993, 3002 HIV+ individuals elder than 13 were diagnosed.
Distribution of risk groups was: 1702 (56.7%) injection drug users IDU;
694 (23.1%) heterosexual way HET; 249 (8.3%) homosexual contacts HO; 127
(4.2%) receptors of blood or blood products; 282 (9.4%) other factors
including unknown ones. Mean age was: IDU 23.8, HET 26.7, HO 30.4.
Female proportion was 29.9%. From 1989 to 1993 HIV+ IDU proportion
decreased (1989 = 70%, 1990 = 66.3%, 1991 = 56.8%, 1992 = 48%, 1993 =
39.4%), while HIV+ HET increased (1989 = 11.8%, 1990 = 18.9%, 1991 =
26.5%, 1992 = 29.8%, 1993 = 30.7%). Rates from Metropolitan Area were
similar than that observed for touristic Atlantic coast, and 10 times
greater than rural zones rates. CONCLUSIONS: 1) the greatest HIV+ risk
group in the Province is IDU; 2) HIV+ HET is an increasing group due to
unprotected sex; 3) It shows how HIV is spreading and ramifying through
our society.
DE Adult Argentina/EPIDEMIOLOGY Female Human HIV
Infections/*EPIDEMIOLOGY HIV Seropositivity *HIV-1 Male Risk Factors
MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).